Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Invesco Water Resources ETF (PHO)

Invesco Water Resources ETF (PHO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MarketBeat.com
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending MarketBeat - Tue Jul 14, 9:45AM CDT

As data centers strain water systems, FIW, PHO, and CGW offer investors ETF-based access to water utilities, infrastructure, and equipment firms, each with distinct fees and concentration.

CGW : 65.76 (-0.24%)
FIW : 108.32 (-1.26%)
PHO : 69.03 (-1.29%)
IDXX : 567.44 (-1.50%)
ECL : 272.83 (-1.04%)
Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer PR Newswire - Mon Jun 8, 12:29PM CDT

OSLO, Norway , June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) , the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative....

PHO : 69.03 (-1.29%)
Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics PR Newswire - Thu Jun 4, 10:46AM CDT

OSLO, Norway , June 4, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) , a leader in bladder cancer diagnostics, today announced the signing and successful completion of its acquisition of Vesica...

PHO : 69.03 (-1.29%)
AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study PR Newswire - Mon May 18, 10:36AM CDT

OSLO, Norway , May 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of two Photocure-supported abstracts at the American Urological Association...

PHO : 69.03 (-1.29%)
Photocure ASA: Results for the first quarter of 2026 PR Newswire - Thu May 7, 1:13AM CDT

OSLO, Norway , May 7, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 139.0 million in the first quarter of 2026 (Q1 2025: NOK...

PHO : 69.03 (-1.29%)
New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer PR Newswire - Mon May 4, 1:29AM CDT

OSLO, Norway , May 4, 2026 /PRNewswire/ --  Photocure ASA (OSE: PHO) , the Bladder Cancer Company, announces the publication in 'The Journal of Medical Economics' of a novel health economics...

PHO : 69.03 (-1.29%)
Photocure ASA: Update on Regulatory Classification for OAY Equipment PR Newswire - Mon Apr 13, 2:30AM CDT

OSLO, Norway , April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue...

PHO : 69.03 (-1.29%)
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway PR Newswire - Mon Mar 16, 11:47AM CDT

OSLO, Norway , March 16, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress...

PHO : 69.03 (-1.29%)
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions PR Newswire - Tue Mar 3, 3:52AM CST

OSLO, Norway , March 3, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today...

PHO : 69.03 (-1.29%)
Photocure ASA: Results for the fourth quarter of 2025 PR Newswire - Wed Feb 18, 12:40AM CST

OSLO, Norway , Feb. 18, 2026 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ®  revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024:...

PHO : 69.03 (-1.29%)

Barchart Exclusives

Alphabet Is Up 94% and Meta Is Down 5%. Barchart Data Helps Pick the Best AI Dividend Stock to Buy Now. Barchart - Fri Jul 17, 6:00PM CDT
Alphabet’s broader ecosystem gives it the long-term edge, while Meta offers faster growth, a lower valuation and a higher yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.